Technology | March 26, 2012

Itamar Launches Cardiovascular Health Assessment Platform at ACC

March 26, 2012 — Itamar-Medical unveiled its cardiovascular healthcare assessment platform, EndoPAT-MF, at the American College of Cardiology’s 61st Annual Scientific Session (ACC.12) in Chicago. The multifunction EndoPAT-MF now features five major diagnostic tools in a single system. In addition to providing the only U.S. Food and Drug Administration (FDA)-cleared, non-invasive measure of endothelial function, the platform also features an augmentation index measuring arterial stiffness and heart rate variability (offering a window onto the autonomic nervous system), as well as leading risk score calculators (Framingham, Reynolds and SCORE) and an integrated Web-based platform, EndoCloud, to provide seamless and efficient patient diagnosis information transfer in a timely manner.

“The fact that heart disease starts in the arteries and blood vessels makes EndoPAT a critical tool for early detection and continued physiological assessment of the health of the vascular system. More than half of all sudden cardiac deaths occur with no previous symptoms and cardiovascular disease continues to be the leading health risk in the United States. Our continued enhancements to EndoPAT offer a significant value in this next-generation tool set for early detection and analysis for patient, payer, provider, and physician,” said Marvin Slosman, president of Itamar-Medical Inc. in the United States.

The EndoPAT-MF will be available upon meeting the regulatory requirements in each of the international geographies. The integrated platform will enable all users to benefit from convenience and cost savings by performing the diagnostic tasks of several devices on a single, unified platform.

For more information:

Related Content

Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics | December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics | December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

The EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

News | Cardiac Diagnostics | November 24, 2017
November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk,
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics | November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics | October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
Overlay Init